Announced Thu, 9 Apr · 21:32 IST

Rights Issue of 3.25 Cr Partly Paid-Up Shares at ₹15 Each

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.7%1-day move

₹11.15

prior close

₹11.96

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-3.8-2.3-3.8-3.8+3.7+6.5+7.6+8.6+7.6+9.1+3.9-0.4+2.7-29.1

Up moveDown movePending

AI summary

Indrayani Biotech's Rights Issue Committee approved issuing 3.25 crore partly paid-up equity shares to raise up to ₹49.90 crore. Price is ₹15 per share (₹10 face value + ₹5 premium), with ₹3.75 payable on application and the balance via future calls. Entitlement ratio is 5 rights shares for every 7 held. Record date is 28 April 2026; issue opens 27 May and closes 25 June 2026. Post-issue share count will rise from 4.55 crore to 7.81 crore assuming full subscription. Axis Bank is the issue banker; India Ratings is monitoring agency.

Likely market impact

Eligible shareholders can subscribe at ₹15 per share; non-participation will dilute their stake. Fund raise of up to ₹49.90 crore.